SYSTEMATIC REVIEW article

Front. Immunol.

Sec. Molecular Innate Immunity

Cell-Type Specificity of Tim-3 in Respiratory Diseases: From Mechanisms to Clinical Translation

  • Bethune International Peace Hospital Library, Shijiazhuang, China

The final, formatted version of the article will be published soon.

Abstract

As an immune checkpoint molecule, Tim-3 is expressed on T cells and other immune cells, and is crucial for maintaining immune homeostasis and preventing excessive inflammation. This article reviews the changes in expression, mechanism of action, and clinical significance of Tim-3 in major respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), pulmonary infections, lung cancer, and pulmonary fibrosis. It emphasizes the dual role (protective and pathogenic) of Tim-3 in respiratory diseases and prospects its potential as a disease biomarker and a new target for immunotherapy.

Summary

Keywords

Immune checkpoint, Immune Regulation, Respiratory diseases, t cell exhaustion, TIM-3

Received

18 December 2025

Accepted

17 February 2026

Copyright

© 2026 Cui, Dou, Jia and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Qi Cui

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Share article

Article metrics